Co-Diagnostics, Inc. Announces Corporate Secretary Changes
July 09, 2021 at 06:03 am
Share
On July 8, 2021, Mr. Reed L. Benson resigned as the Corporate Secretary of Co-Diagnostics, Inc., a Utah corporation (the “Company”). Mr. Benson had served as the Company’s Corporate Secretary since its inception in April 2013. Mr. Benson’s resignation as Corporate Secretary was not the result of any disagreement with the Company’s management or Board of Directors relating to the Company’s operations, policies, or practices. Mr. Benson will remain an employee of the Company in the role of general counsel. On July 8, 2021, the Company’s Board of Directors appointed Brian L. Brown, CPA, as the Company’s Corporate Secretary. As previously reported in a Form 8-K filed by the Company on February 22, 2021, Mr. Brown was appointed as the Company’s Chief Financial Officer on February 22, 2021, and will remain in such position.
Co-Diagnostics, Inc. is a molecular diagnostics company, which develops, manufactures and markets diagnostics technologies. The Companyâs technologies are utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR platform and to locate genetic markers for use in applications other than infectious disease. Its diagnostics systems enable dependable, low-cost, molecular testing for organisms and genetic diseases by automating or simplifying historically complex procedures in both the development and administration of tests. It is developing a portable diagnostic device and test system designed for point-of-care and at-home use. The system consists of its PCR instrument that it refers to as the Co-Dx PCR Pro instrument, its proprietary diagnostic test cup system and a mobile application to be installed on the userâs mobile device.
CO-DIAGNOSTICS, INC. 
